Adverse events, short- and long-term outcomes of extra corporeal liver therapy in the intensive care unit: 16 years experience with MARS® in a single center.

MLA

Monet, Clément, et al. “Adverse Events, Short- and Long-Term Outcomes of Extra Corporeal Liver Therapy in the Intensive Care Unit: 16 Years Experience with MARS® in a Single Center.” Critical Care, vol. 26, no. 1, Sept. 2022, pp. 1–13. EBSCOhost, https://doi.org/10.1186/s13054-022-04165-z.

APA

Monet, C., De Jong, A., Aarab, Y., Piron, L., Prades, A., Carr, J., Belafia, F., Chanques, G., Guiu, B., Pageaux, G.-P., & Jaber, S. (2022). Adverse events, short- and long-term outcomes of extra corporeal liver therapy in the intensive care unit: 16 years experience with MARS® in a single center. Critical Care, 26(1), 1–13. https://doi.org/10.1186/s13054-022-04165-z

Chicago

Monet, Clément, Audrey De Jong, Yassir Aarab, Lauranne Piron, Albert Prades, Julie Carr, Fouad Belafia, et al. 2022. “Adverse Events, Short- and Long-Term Outcomes of Extra Corporeal Liver Therapy in the Intensive Care Unit: 16 Years Experience with MARS® in a Single Center.” Critical Care 26 (1): 1–13. doi:10.1186/s13054-022-04165-z.